Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for January 2007
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Exubera approval limited to needle-phobic patients
But NICE drops psychiatric consultation stipulation ..(more)

 Merck Serono picks Huntsworth for infertility work
Account is latest in series of major wins for relaunched agency..(more)

 Januvia set for EU approval
Final clearnace for the potential blockbuster expected in three months..(more)

 Lucentis approved in Europe
Drug will be rival to Pfizer's Macugen..(more)

 New website to promote patient choice
But scheme meets resistance from GPs..(more)

 Work to begin on new NHS cancer strategy
Government says it aims to respond to patient needs..(more)

 Vectura buys Innovata for £131 million
Acquisition could create a UK leader in pulmonary product development..(more)

 Novartis readies Prexige for osteoarthritis launch in Europe
Side-effect doubts overcome using data from 34,000 patients..(more)

 Pfizer ponders over-the-counter Viagra
Company hopes to reinvigorate stagnating sales..(more)

 NICE authority hangs in the balance ahead of court ruling
Tough talk as NICE condemns Eisai's Alzheimer's drug challenge..(more)

 New software to cut unnecessary hospital stays
Patients at risk of frequent hospitalisation to be identified and treated earlier..(more)

 World's first stem cell trial for stroke likely to get green light
ReNeuron hopes ReN001 will pave the way for other stem cell therapies..(more)

 AZ and Lilly set to follow Pfizer on supply chain
Move would stop counterfeiters - but also parallel imports..(more)

 AZ and BMS combine to develop new diabetes drugs
BMS could receive up to $750 million from deal..(more)

 Wellcome Trust issues first grants to encourage drug discovery
Obesity, MRSA and cancer drug developments receive funding boost..(more)

 Minister's promotion of statin switching proves controversial
Pharma companies and GPs say policy risks lives of patients..(more)

 Fast-track 'not a soft option' says NICE
Burden of proof to remain with drug manufacturers ..(more)

 Novartis plans eight launches for 2007
Salesforce may need to be expanded to rapidly maximise sales..(more)

 Future of Alzheimer's drugs lies with the High Court
Eisai requests judicial review to investigate NICE's controversial decision..(more)

 New class of anti-angiogenesis agents gets 2 million euro boost
Consortium to develop drug for tumours, inflammation and eye disease..(more)

 Europe's biotech sector to flourish in 2007
Sector expected to outsrip US growth as it did in 2006..(more)

 UK pharma is going green
Pfizer and GSK lead the way with eco-friendly initiatives..(more)

 Roche targets new central nervous system drugs
Synosis to develop five drug candidates in new partnership..(more)

 Diabetic kidney disease drug hits safety obstacle
Phase III trials of SPP301 halted after fluid retention problem found in patients..(more)

 GSK buys Praecis Pharmaceuticals for $59 million
Purchase is further addition to GSK's cancer drug programme..(more)

 Hants NHS hospital becomes first to be run by private sector
But Unison fears the move is an "enormous gamble"..(more)

 Positive EU opinion for pancreatic cancer drug Tarceva
But high cost could hamper its success in Europe..(more)

 NHS must undergo massive change to meet new waiting list target
18-week referral to treatment time to be achieved by 2009..(more)

 GSK invests millions in new leukaemia drug
GSK joins with Genmab in deal which could eventually cost it £1bn..(more)

 Novartis enters late-stage trials for new hepatitis C drug
Company teams up with US-based HGS to bring combination drug to market..(more)

 Government accused of 'fiddling the books'
Doctor says PCTs withholding PBC budgets from GP practices..(more)

 Pfizer launches online pipeline tracker
Company aims to satisfy investors' demands for R&D transparency..(more)

 New consultancy to address pharma's NHS funding challenge
HGS aims to make drug launching a smoother process for companies..(more)

 Pharma failing to address MRSA drugs market
New 'superbug' highlights need for effective antibiotics..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.